Urocortin 2 modulates aspects of social behaviour in mice

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 331-336

  Breu, Johannes ^a   Touma, Chadi ^a   Hölter, Sabine M ^b   Knapman, Alana ^a   Wurst, Wolfgang ^a,b,c,d   Deussing, Jan M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Attack latency test; CRH R2, Social behaviour; Knockout; Social interaction; Urocortin 2

Indexed keywords

UROCORTIN II;

AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HORMONE ACTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; AGGRESSION; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ODORS; OLFACTORY PERCEPTION; PITUITARY-ADRENAL SYSTEM; REACTION TIME; SEX FACTORS; STATISTICS, NONPARAMETRIC; SWIMMING; UROCORTINS;

EID: 84862204654     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.031     Document Type: Article

References (30)

1. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology 2004, 44:525-557.
2. Zorrilla E.P., Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opinion on Investigational Drugs 2004, 13:799-828.
3. Refojo D., Holsboer F. CRH signaling. Molecular specificity for drug targeting in the CNS. Annals of the New York Academy of Sciences 2009, 1179:106-119.
4. Muller M.B., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 2003, 6:1100-1107.
5. Refojo D., Schweizer M., Kuehne C., Ehrenberg S., Thoeringer C., Vogl A.M., et al. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 2011, 333:1903-1907.
6. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
7. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics 1998, 19:162-166.
8. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics 2000, 24:410-414.
9. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genetics 2000, 24:403-409.
10. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genetics 2000, 24:415-419.
11. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2843-2848.
12. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Research 2002, 943:142-150.
13. Henry B., Vale W., Markou A. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. Journal of Neuroscience 2006, 26:9142-9152.
14. Chen A., Zorrilla E., Smith S., Rousso D., Levy C., Vaughan J., et al. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. Journal of Neuroscience 2006, 26:5500-5510.
15. Deussing J.M., Breu J., Kuhne C., Kallnik M., Bunck M., Glasl L., et al. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. Journal of Neuroscience 2010, 30:9103-9116.
16. File S.E., Hyde J.R. Can social interaction be used to measure anxiety. British Journal of Pharmacology 1978, 62:19-24.
17. Tonissaar M., Philips M.A., Eller M., Harro J. Sociability trait and serotonin metabolism in the rat social interaction test. Neuroscience Letters 2004, 367:309-312.
18. Ebner K., Wotjak C.T., Landgraf R., Engelmann M. Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats. European Journal of Neuroscience 2002, 15:384-388.
19. Touma C., Bunck M., Glasl L., Nussbaumer M., Palme R., Stein H., et al. Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology 2008, 33:839-862.
20. Tanaka M., Telegdy G. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice. Brain Research Bulletin 2008, 75:509-512.
21. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Research 2003, 980:206-212.
22. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
23. Neufeld-Cohen A., Evans A.K., Getselter D., Spyroglou A., Hill A., Gil S., et al. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Molecular Psychiatry 2010, 15:426-441. 339.
24. Coste S.C., Murray S.E., Stenzel-Poore M.P. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 2001, 22:733-741.
25. Deussing J.M., Wurst W. Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour. Comptes Rendus Biologies 2005, 328:199-212.
26. Heinrichs S.C. Modulation of social learning in rats by brain corticotropin-releasing factor. Brain Research 2003, 994:107-114.
27. Kasahara M., Groenink L., Kas M.J., Bijlsma E.Y., Olivier B., Sarnyai Z. Influence of transgenic corticotropin-releasing factor (CRF) over-expression on social recognition memory in mice. Behavioural Brain Research 2011, 218:357-362.
28. D'Anna K.L., Stevenson S.A., Gammie S.C. Urocortin 1 and 3 impair maternal defense behavior in mice. Behavioral Neuroscience 2005, 119:1061-1071.
29. D'Anna K.L., Gammie S.C. Activation of corticotropin-releasing factor receptor 2 in lateral septum negatively regulates maternal defense. Behavioral Neuroscience 2009, 123:356-368.
30. Gammie S.C., Hasen N.S., Stevenson S.A., Bale T.L., D'Anna K.L. Elevated stress sensitivity in corticotropin-releasing factor receptor 2 deficient mice decreases maternal, but not intermale aggression. Behavioural Brain Research 2005, 160:169-177.